The Tumor Inflammation Signature (TIS) is a measurement of the adaptive immune response in a tumor. The TIS incorporates expression of 18 genes involved in important adaptive immune functions including antigen presentation, chemokine expression, and cytotoxic activity. TIS is correlated with response to anti-PD-1 immunotherapy.